<unk>  (Zyprexa, Zyprexa Zydis, or in combination with fluoxetine Symbyax) is an atypical antipsychotic, approved by the FDA in 1996 for the treatment of schizophrenia, acute manic episodes in bipolar disorder, acute agitation associated with both these disorders, maintenance treatment in bipolar disorder, and, as the Symbyax formulation, for the treatment of depressive episodes associated with bipolar disorder. Off-label uses are listed below.<unk>  is manufactured and marketed by the pharmaceutical company Eli Lilly and Company, whose patent for<unk>  proper ends in 2011.
Olanzapine detailed information
Fluoxetine detailed information
Amitriptyline detailed information
Temazepam detailed information
Alprazolam detailed information
Anhedonia future or investigational therapies
Donepezil detailed information
Suicidal ideation medical therapy